Climb Bio (CLYM) Shares Outstanding (2020 - 2026)

Climb Bio (CLYM) has 7 years of Shares Outstanding (Entity) data on file, last reported at $68.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 0.93% year-over-year to $68.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.2 million (up 0.93% YoY) and the FY2025 annual result came in at $67.8 million, up 40.8% from the prior year.
• Shares Outstanding (Entity) improved to $68.2 million in Q1 2026, from $67.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $68.2 million in Q1 2026 to a low of $26.2 million in Q1 2022.
• A 5-year average of $42.8 million and a median of $27.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) soared 654.38% — and 2026, when it rose 0.93%.
• Tracing CLYM's Shares Outstanding (Entity) over 5 years: stood at $26.4 million in 2022, then climbed by 4.68% to $27.6 million in 2023, then soared by 74.34% to $48.2 million in 2024, then surged by 40.8% to $67.8 million in 2025, then increased by 0.58% to $68.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $68.2 million (Q1 2026), $67.8 million (Q4 2025), and $68.2 million (Q3 2025), per Business Quant data.